nodes	percent_of_prediction	percent_of_DWPC	metapath
Potassium Chloride—SLC12A7—saliva-secreting gland—thyroid cancer	0.0451	0.102	CbGeAlD
Potassium Chloride—SLC12A6—thyroid gland—thyroid cancer	0.0361	0.0814	CbGeAlD
Potassium Chloride—SLC12A7—trachea—thyroid cancer	0.0348	0.0785	CbGeAlD
Potassium Chloride—SLC12A6—head—thyroid cancer	0.032	0.0722	CbGeAlD
Potassium Chloride—SLC12A2—saliva-secreting gland—thyroid cancer	0.0294	0.0664	CbGeAlD
Potassium Chloride—SLC12A5—head—thyroid cancer	0.0278	0.0628	CbGeAlD
Potassium Chloride—SLC12A7—thyroid gland—thyroid cancer	0.0275	0.0621	CbGeAlD
Potassium Chloride—SLC12A4—thyroid gland—thyroid cancer	0.026	0.0588	CbGeAlD
Potassium Chloride—SLC12A7—head—thyroid cancer	0.0244	0.0551	CbGeAlD
Potassium Chloride—SLC12A4—head—thyroid cancer	0.0231	0.0521	CbGeAlD
Potassium Chloride—SLC12A2—trachea—thyroid cancer	0.0227	0.0513	CbGeAlD
Potassium Chloride—SLC12A6—lymph node—thyroid cancer	0.0224	0.0506	CbGeAlD
Potassium Chloride—Ileus—Vandetanib—thyroid cancer	0.018	0.0644	CcSEcCtD
Potassium Chloride—SLC12A2—thyroid gland—thyroid cancer	0.018	0.0405	CbGeAlD
Potassium Chloride—SLC12A7—lymph node—thyroid cancer	0.0171	0.0386	CbGeAlD
Potassium Chloride—SLC12A4—lymph node—thyroid cancer	0.0162	0.0365	CbGeAlD
Potassium Chloride—SLC12A2—head—thyroid cancer	0.0159	0.036	CbGeAlD
Potassium Chloride—SLC12A7—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—thyroid cancer	0.0154	0.0555	CbGpPWpGaD
Potassium Chloride—SLC12A6—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—thyroid cancer	0.0154	0.0555	CbGpPWpGaD
Potassium Chloride—SLC12A1—head—thyroid cancer	0.0134	0.0302	CbGeAlD
Potassium Chloride—SLC12A5—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—thyroid cancer	0.0117	0.0421	CbGpPWpGaD
Potassium Chloride—SLC12A4—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—thyroid cancer	0.0117	0.0421	CbGpPWpGaD
Potassium Chloride—SLC12A2—lymph node—thyroid cancer	0.0112	0.0252	CbGeAlD
Potassium Chloride—SLC12A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—thyroid cancer	0.00992	0.0358	CbGpPWpGaD
Potassium Chloride—Hyponatraemia—Vandetanib—thyroid cancer	0.00929	0.0332	CcSEcCtD
Potassium Chloride—Gastrointestinal haemorrhage—Vandetanib—thyroid cancer	0.00925	0.0331	CcSEcCtD
Potassium Chloride—SLC12A7—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.00919	0.0331	CbGpPWpGaD
Potassium Chloride—SLC12A6—SLC-mediated transmembrane transport—CP—thyroid cancer	0.00919	0.0331	CbGpPWpGaD
Potassium Chloride—SLC12A7—SLC-mediated transmembrane transport—CP—thyroid cancer	0.00919	0.0331	CbGpPWpGaD
Potassium Chloride—SLC12A6—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.00919	0.0331	CbGpPWpGaD
Potassium Chloride—Cardiac arrest—Vandetanib—thyroid cancer	0.0088	0.0315	CcSEcCtD
Potassium Chloride—SLC12A5—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.00697	0.0251	CbGpPWpGaD
Potassium Chloride—SLC12A4—SLC-mediated transmembrane transport—CP—thyroid cancer	0.00697	0.0251	CbGpPWpGaD
Potassium Chloride—SLC12A5—SLC-mediated transmembrane transport—CP—thyroid cancer	0.00697	0.0251	CbGpPWpGaD
Potassium Chloride—SLC12A4—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.00697	0.0251	CbGpPWpGaD
Potassium Chloride—SLC12A7—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.00688	0.0248	CbGpPWpGaD
Potassium Chloride—SLC12A6—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.00688	0.0248	CbGpPWpGaD
Potassium Chloride—Haemoglobin—Vandetanib—thyroid cancer	0.00643	0.023	CcSEcCtD
Potassium Chloride—Haemorrhage—Vandetanib—thyroid cancer	0.0064	0.0229	CcSEcCtD
Potassium Chloride—Hyponatraemia—Sorafenib—thyroid cancer	0.00627	0.0224	CcSEcCtD
Potassium Chloride—SLC12A2—SLC-mediated transmembrane transport—CP—thyroid cancer	0.00592	0.0214	CbGpPWpGaD
Potassium Chloride—SLC12A2—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.00592	0.0214	CbGpPWpGaD
Potassium Chloride—SLC12A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—thyroid cancer	0.0059	0.0213	CbGpPWpGaD
Potassium Chloride—Venous thrombosis—Epirubicin—thyroid cancer	0.00589	0.0211	CcSEcCtD
Potassium Chloride—Arrhythmia—Vandetanib—thyroid cancer	0.00572	0.0205	CcSEcCtD
Potassium Chloride—Venous thrombosis—Doxorubicin—thyroid cancer	0.00545	0.0195	CcSEcCtD
Potassium Chloride—SLC12A4—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.00521	0.0188	CbGpPWpGaD
Potassium Chloride—SLC12A5—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.00521	0.0188	CbGpPWpGaD
Potassium Chloride—Abdominal discomfort—Sorafenib—thyroid cancer	0.00517	0.0185	CcSEcCtD
Potassium Chloride—SLC12A7—Transmembrane transport of small molecules—TPR—thyroid cancer	0.00467	0.0168	CbGpPWpGaD
Potassium Chloride—SLC12A6—Transmembrane transport of small molecules—CP—thyroid cancer	0.00467	0.0168	CbGpPWpGaD
Potassium Chloride—SLC12A7—Transmembrane transport of small molecules—CP—thyroid cancer	0.00467	0.0168	CbGpPWpGaD
Potassium Chloride—SLC12A6—Transmembrane transport of small molecules—TPR—thyroid cancer	0.00467	0.0168	CbGpPWpGaD
Potassium Chloride—SLC12A7—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.00459	0.0166	CbGpPWpGaD
Potassium Chloride—SLC12A6—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.00459	0.0166	CbGpPWpGaD
Potassium Chloride—Infection—Vandetanib—thyroid cancer	0.00452	0.0162	CcSEcCtD
Potassium Chloride—Ileus—Epirubicin—thyroid cancer	0.00449	0.0161	CcSEcCtD
Potassium Chloride—SLC12A2—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.00443	0.016	CbGpPWpGaD
Potassium Chloride—Haemoglobin—Sorafenib—thyroid cancer	0.00434	0.0155	CcSEcCtD
Potassium Chloride—Haemorrhage—Sorafenib—thyroid cancer	0.00432	0.0154	CcSEcCtD
Potassium Chloride—Ileus—Doxorubicin—thyroid cancer	0.00415	0.0149	CcSEcCtD
Potassium Chloride—Paraesthesia—Vandetanib—thyroid cancer	0.00408	0.0146	CcSEcCtD
Potassium Chloride—Necrosis—Epirubicin—thyroid cancer	0.00405	0.0145	CcSEcCtD
Potassium Chloride—Abscess—Epirubicin—thyroid cancer	0.00402	0.0144	CcSEcCtD
Potassium Chloride—Pain—Vandetanib—thyroid cancer	0.00389	0.0139	CcSEcCtD
Potassium Chloride—Arrhythmia—Sorafenib—thyroid cancer	0.00386	0.0138	CcSEcCtD
Potassium Chloride—Necrosis—Doxorubicin—thyroid cancer	0.00375	0.0134	CcSEcCtD
Potassium Chloride—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00372	0.0133	CcSEcCtD
Potassium Chloride—Abscess—Doxorubicin—thyroid cancer	0.00372	0.0133	CcSEcCtD
Potassium Chloride—Extravasation—Epirubicin—thyroid cancer	0.00364	0.013	CcSEcCtD
Potassium Chloride—Body temperature increased—Vandetanib—thyroid cancer	0.00359	0.0129	CcSEcCtD
Potassium Chloride—Abdominal pain—Vandetanib—thyroid cancer	0.00359	0.0129	CcSEcCtD
Potassium Chloride—SLC12A4—Transmembrane transport of small molecules—CP—thyroid cancer	0.00354	0.0128	CbGpPWpGaD
Potassium Chloride—SLC12A4—Transmembrane transport of small molecules—TPR—thyroid cancer	0.00354	0.0128	CbGpPWpGaD
Potassium Chloride—SLC12A5—Transmembrane transport of small molecules—CP—thyroid cancer	0.00354	0.0128	CbGpPWpGaD
Potassium Chloride—SLC12A5—Transmembrane transport of small molecules—TPR—thyroid cancer	0.00354	0.0128	CbGpPWpGaD
Potassium Chloride—SLC12A1—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.00352	0.0127	CbGpPWpGaD
Potassium Chloride—SLC12A1—SLC-mediated transmembrane transport—CP—thyroid cancer	0.00352	0.0127	CbGpPWpGaD
Potassium Chloride—SLC12A6—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.0035	0.0126	CbGpPWpGaD
Potassium Chloride—SLC12A7—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.0035	0.0126	CbGpPWpGaD
Potassium Chloride—SLC12A4—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.00348	0.0126	CbGpPWpGaD
Potassium Chloride—SLC12A5—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.00348	0.0126	CbGpPWpGaD
Potassium Chloride—Extravasation—Doxorubicin—thyroid cancer	0.00337	0.0121	CcSEcCtD
Potassium Chloride—Dysarthria—Epirubicin—thyroid cancer	0.00336	0.012	CcSEcCtD
Potassium Chloride—Ulcer—Epirubicin—thyroid cancer	0.00336	0.012	CcSEcCtD
Potassium Chloride—Atrioventricular block—Epirubicin—thyroid cancer	0.00328	0.0117	CcSEcCtD
Potassium Chloride—Asthenia—Vandetanib—thyroid cancer	0.00326	0.0117	CcSEcCtD
Potassium Chloride—Hyperkalaemia—Epirubicin—thyroid cancer	0.00312	0.0112	CcSEcCtD
Potassium Chloride—Diarrhoea—Vandetanib—thyroid cancer	0.00311	0.0111	CcSEcCtD
Potassium Chloride—Dysarthria—Doxorubicin—thyroid cancer	0.00311	0.0111	CcSEcCtD
Potassium Chloride—Ulcer—Doxorubicin—thyroid cancer	0.00311	0.0111	CcSEcCtD
Potassium Chloride—Infection—Sorafenib—thyroid cancer	0.00305	0.0109	CcSEcCtD
Potassium Chloride—Atrioventricular block—Doxorubicin—thyroid cancer	0.00303	0.0108	CcSEcCtD
Potassium Chloride—SLC12A2—Transmembrane transport of small molecules—TPR—thyroid cancer	0.00301	0.0109	CbGpPWpGaD
Potassium Chloride—SLC12A2—Transmembrane transport of small molecules—CP—thyroid cancer	0.00301	0.0109	CbGpPWpGaD
Potassium Chloride—SLC12A2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.00296	0.0107	CbGpPWpGaD
Potassium Chloride—SLC12A7—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.00294	0.0106	CbGpPWpGaD
Potassium Chloride—SLC12A6—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.00294	0.0106	CbGpPWpGaD
Potassium Chloride—Vomiting—Vandetanib—thyroid cancer	0.00289	0.0103	CcSEcCtD
Potassium Chloride—Hyperkalaemia—Doxorubicin—thyroid cancer	0.00289	0.0103	CcSEcCtD
Potassium Chloride—Rash—Vandetanib—thyroid cancer	0.00287	0.0103	CcSEcCtD
Potassium Chloride—Dermatitis—Vandetanib—thyroid cancer	0.00286	0.0102	CcSEcCtD
Potassium Chloride—Nausea—Vandetanib—thyroid cancer	0.0027	0.00966	CcSEcCtD
Potassium Chloride—Phlebitis—Epirubicin—thyroid cancer	0.00268	0.00958	CcSEcCtD
Potassium Chloride—SLC12A5—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.00265	0.00956	CbGpPWpGaD
Potassium Chloride—SLC12A4—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.00265	0.00956	CbGpPWpGaD
Potassium Chloride—SLC12A1—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.00264	0.00951	CbGpPWpGaD
Potassium Chloride—Pain—Sorafenib—thyroid cancer	0.00262	0.00938	CcSEcCtD
Potassium Chloride—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00251	0.00897	CcSEcCtD
Potassium Chloride—Phlebitis—Doxorubicin—thyroid cancer	0.00248	0.00886	CcSEcCtD
Potassium Chloride—Body temperature increased—Sorafenib—thyroid cancer	0.00243	0.00868	CcSEcCtD
Potassium Chloride—Abdominal pain—Sorafenib—thyroid cancer	0.00243	0.00868	CcSEcCtD
Potassium Chloride—Hyponatraemia—Epirubicin—thyroid cancer	0.00232	0.00829	CcSEcCtD
Potassium Chloride—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.00231	0.00825	CcSEcCtD
Potassium Chloride—SLC12A2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.00225	0.00813	CbGpPWpGaD
Potassium Chloride—SLC12A5—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.00223	0.00803	CbGpPWpGaD
Potassium Chloride—SLC12A4—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.00223	0.00803	CbGpPWpGaD
Potassium Chloride—Asthenia—Sorafenib—thyroid cancer	0.0022	0.00787	CcSEcCtD
Potassium Chloride—Cardiac arrest—Epirubicin—thyroid cancer	0.00219	0.00785	CcSEcCtD
Potassium Chloride—Hyponatraemia—Doxorubicin—thyroid cancer	0.00214	0.00767	CcSEcCtD
Potassium Chloride—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.00213	0.00764	CcSEcCtD
Potassium Chloride—Diarrhoea—Sorafenib—thyroid cancer	0.0021	0.00751	CcSEcCtD
Potassium Chloride—Cardiac arrest—Doxorubicin—thyroid cancer	0.00203	0.00726	CcSEcCtD
Potassium Chloride—Vomiting—Sorafenib—thyroid cancer	0.00195	0.00698	CcSEcCtD
Potassium Chloride—Rash—Sorafenib—thyroid cancer	0.00193	0.00692	CcSEcCtD
Potassium Chloride—Dermatitis—Sorafenib—thyroid cancer	0.00193	0.00691	CcSEcCtD
Potassium Chloride—SLC12A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.00189	0.00683	CbGpPWpGaD
Potassium Chloride—Nausea—Sorafenib—thyroid cancer	0.00182	0.00652	CcSEcCtD
Potassium Chloride—SLC12A1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.00179	0.00645	CbGpPWpGaD
Potassium Chloride—SLC12A1—Transmembrane transport of small molecules—CP—thyroid cancer	0.00179	0.00645	CbGpPWpGaD
Potassium Chloride—SLC12A1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.00176	0.00635	CbGpPWpGaD
Potassium Chloride—Haemoglobin—Epirubicin—thyroid cancer	0.0016	0.00574	CcSEcCtD
Potassium Chloride—Haemorrhage—Epirubicin—thyroid cancer	0.0016	0.00571	CcSEcCtD
Potassium Chloride—Haemoglobin—Doxorubicin—thyroid cancer	0.00148	0.00531	CcSEcCtD
Potassium Chloride—Haemorrhage—Doxorubicin—thyroid cancer	0.00148	0.00528	CcSEcCtD
Potassium Chloride—Arrhythmia—Epirubicin—thyroid cancer	0.00143	0.0051	CcSEcCtD
Potassium Chloride—Flatulence—Epirubicin—thyroid cancer	0.00137	0.0049	CcSEcCtD
Potassium Chloride—SLC12A1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.00134	0.00483	CbGpPWpGaD
Potassium Chloride—Arrhythmia—Doxorubicin—thyroid cancer	0.00132	0.00472	CcSEcCtD
Potassium Chloride—Flatulence—Doxorubicin—thyroid cancer	0.00127	0.00453	CcSEcCtD
Potassium Chloride—Discomfort—Epirubicin—thyroid cancer	0.00117	0.00418	CcSEcCtD
Potassium Chloride—Confusional state—Epirubicin—thyroid cancer	0.00114	0.00409	CcSEcCtD
Potassium Chloride—Infection—Epirubicin—thyroid cancer	0.00113	0.00403	CcSEcCtD
Potassium Chloride—SLC12A1—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.00113	0.00406	CbGpPWpGaD
Potassium Chloride—Discomfort—Doxorubicin—thyroid cancer	0.00108	0.00387	CcSEcCtD
Potassium Chloride—Hypotension—Epirubicin—thyroid cancer	0.00106	0.00379	CcSEcCtD
Potassium Chloride—Confusional state—Doxorubicin—thyroid cancer	0.00106	0.00378	CcSEcCtD
Potassium Chloride—Infection—Doxorubicin—thyroid cancer	0.00104	0.00373	CcSEcCtD
Potassium Chloride—Paraesthesia—Epirubicin—thyroid cancer	0.00102	0.00364	CcSEcCtD
Potassium Chloride—Hypotension—Doxorubicin—thyroid cancer	0.00098	0.00351	CcSEcCtD
Potassium Chloride—Pain—Epirubicin—thyroid cancer	0.000969	0.00347	CcSEcCtD
Potassium Chloride—Paraesthesia—Doxorubicin—thyroid cancer	0.000942	0.00337	CcSEcCtD
Potassium Chloride—Feeling abnormal—Epirubicin—thyroid cancer	0.000934	0.00334	CcSEcCtD
Potassium Chloride—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000927	0.00332	CcSEcCtD
Potassium Chloride—Pain—Doxorubicin—thyroid cancer	0.000897	0.00321	CcSEcCtD
Potassium Chloride—Abdominal pain—Epirubicin—thyroid cancer	0.000896	0.00321	CcSEcCtD
Potassium Chloride—Body temperature increased—Epirubicin—thyroid cancer	0.000896	0.00321	CcSEcCtD
Potassium Chloride—Feeling abnormal—Doxorubicin—thyroid cancer	0.000864	0.00309	CcSEcCtD
Potassium Chloride—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000858	0.00307	CcSEcCtD
Potassium Chloride—Body temperature increased—Doxorubicin—thyroid cancer	0.000829	0.00297	CcSEcCtD
Potassium Chloride—Abdominal pain—Doxorubicin—thyroid cancer	0.000829	0.00297	CcSEcCtD
Potassium Chloride—Asthenia—Epirubicin—thyroid cancer	0.000813	0.00291	CcSEcCtD
Potassium Chloride—Diarrhoea—Epirubicin—thyroid cancer	0.000776	0.00277	CcSEcCtD
Potassium Chloride—Asthenia—Doxorubicin—thyroid cancer	0.000753	0.00269	CcSEcCtD
Potassium Chloride—Vomiting—Epirubicin—thyroid cancer	0.000721	0.00258	CcSEcCtD
Potassium Chloride—Diarrhoea—Doxorubicin—thyroid cancer	0.000718	0.00257	CcSEcCtD
Potassium Chloride—Rash—Epirubicin—thyroid cancer	0.000715	0.00256	CcSEcCtD
Potassium Chloride—Dermatitis—Epirubicin—thyroid cancer	0.000714	0.00255	CcSEcCtD
Potassium Chloride—Nausea—Epirubicin—thyroid cancer	0.000673	0.00241	CcSEcCtD
Potassium Chloride—Vomiting—Doxorubicin—thyroid cancer	0.000667	0.00239	CcSEcCtD
Potassium Chloride—Rash—Doxorubicin—thyroid cancer	0.000661	0.00237	CcSEcCtD
Potassium Chloride—Dermatitis—Doxorubicin—thyroid cancer	0.000661	0.00236	CcSEcCtD
Potassium Chloride—Nausea—Doxorubicin—thyroid cancer	0.000623	0.00223	CcSEcCtD
